Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × saracatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Liver Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1 Dermatofibrosarcoma 1 Colonic Neoplasms 1 Choriocarcinoma 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 134 Paclitaxel 122 Bevacizumab 69 Gemcitabine 37 Taxes 36 liposomal doxorubicin 33 Cisplatin 30 pembrolizumab 29 Topotecan 27 olaparib 21 Cyclophosphamide 21 Specimen Handling 19 Immunoglobulin G 19 Disulfides 19 Drug Therapy 17 Docetaxel 17 Magnetic Resonance Spectroscopy 15 Doxorubicin 14 Biopsy 14 niraparib 13 mirvetuximab soravtansine 13 Hyperthermic Intraperitoneal Chemotherapy 12 Nivolumab 11 rucaparib 10 Cytoreduction Surgical Procedures 10 Chemotherapy, Adjuvant 10 Platinum 8 Neoadjuvant Therapy 8 Albumin-Bound Paclitaxel 8 veliparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01196741 2015-05-05

SaPPrOC

University College, London

Phase 2/3 Completed

107 enrolled 17 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡